Zymeworks Inc.
ZYME · NASDAQ
Το Bulios Scoring περιγράφει την ποιότητα και το ιστορικό μιας εταιρείας, όχι τη μελλοντική απόδοση. Ένα υψηλό σκορ δεν είναι σήμα αγοράς. Μάθετε περισσότερα
Σχετικά με την εταιρεία
Zymeworks Inc. (ZYME) is a Canadian biotechnology company specializing in the development of biologic drugs and therapies for oncological diseases and other serious conditions. With activities in biotechnology and pharmacology, Zymeworks Inc. is a key player in the world of innovative treatment approaches for various diseases. Their research focuses on discovering new biologic therapies and drugs that target specific biological mechanisms and pathways within the body. The company aims to provide modern and targeted treatment solutions that can bring new hope to patients with oncological and other serious diseases. Zymeworks Inc. is characterized by a high level of expertise in biotechnology and medicine. Zymeworks Inc. (ZYME) shares could be suitable for investors looking for an investment opportunity in the biotechnology sector with a company that specializes in innovative biologic treatment approaches and therapies for various serious conditions.
Δεν είναι ακόμη διαθέσιμο στη γλώσσα σας, επομένως το κείμενο είναι στα αγγλικά.
Sector
Healthcare
Industry
Biotechnology
CEO
Kenneth H. Galbraith
Employees
231
Headquarters
Middletown
Επερχόμενα γεγονότα
Earnings
Upcoming earnings report